206 related articles for article (PubMed ID: 12151385)
1. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane.
Suzuki C; Murakami G; Fukuchi M; Shimanuki T; Shikauchi Y; Imamura T; Miyazono K
J Biol Chem; 2002 Oct; 277(42):39919-25. PubMed ID: 12151385
[TBL] [Abstract][Full Text] [Related]
2. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7.
Tajima Y; Goto K; Yoshida M; Shinomiya K; Sekimoto T; Yoneda Y; Miyazono K; Imamura T
J Biol Chem; 2003 Mar; 278(12):10716-21. PubMed ID: 12519765
[TBL] [Abstract][Full Text] [Related]
4. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
6. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
[TBL] [Abstract][Full Text] [Related]
7. Control of Smad7 stability by competition between acetylation and ubiquitination.
Grönroos E; Hellman U; Heldin CH; Ericsson J
Mol Cell; 2002 Sep; 10(3):483-93. PubMed ID: 12408818
[TBL] [Abstract][Full Text] [Related]
8. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
Kavsak P; Rasmussen RK; Causing CG; Bonni S; Zhu H; Thomsen GH; Wrana JL
Mol Cell; 2000 Dec; 6(6):1365-75. PubMed ID: 11163210
[TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
11. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
Ying SX; Hussain ZJ; Zhang YE
J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
13. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor.
Yamaguchi T; Kurisaki A; Yamakawa N; Minakuchi K; Sugino H
J Mol Endocrinol; 2006 Jun; 36(3):569-79. PubMed ID: 16720724
[TBL] [Abstract][Full Text] [Related]
14. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation.
Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A
EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
[TBL] [Abstract][Full Text] [Related]
16. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain.
Ogunjimi AA; Briant DJ; Pece-Barbara N; Le Roy C; Di Guglielmo GM; Kavsak P; Rasmussen RK; Seet BT; Sicheri F; Wrana JL
Mol Cell; 2005 Aug; 19(3):297-308. PubMed ID: 16061177
[TBL] [Abstract][Full Text] [Related]
18. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617
[TBL] [Abstract][Full Text] [Related]
19. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
20. Molecular Analysis of Membrane Targeting by the C2 Domain of the E3 Ubiquitin Ligase Smurf1.
Scott JL; Frick CT; Johnson KA; Liu H; Yong SS; Varney AG; Wiest O; Stahelin RV
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
